We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Reprogramming Rapamycin to Create New Small Molecule Drugs

News   Feb 28, 2019 | Original story from the University of Helsinki

 
Reprogramming Rapamycin to Create New Small Molecule Drugs
 
 
Advertisement
 

RELATED ARTICLES

New Model Could Improve Design of Vaccines and Immunotherapies

News

Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have discovered a general property for understanding how immune cells sense and respond to microbial signals.

READ MORE

Structure of Potent Antibody Against SARS-CoV-2 Is Mapped

News

Scientists at Fred Hutchinson Cancer Research Center in Seattle have shown that a potent antibody from a COVID-19 survivor interferes with a key feature on the surface of the coronavirus’s distinctive spikes, causing them to drop off.

READ MORE

Avoiding Side Effects Associated With Cancer Treatment

News

Researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital/University of Luassanne (CHUV/UNIL) may have found a way to treat cancer without the onset of debilitating side effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE